Ford JM - Search Results

1

Poly (ADP-ribose) polymerase inhibitor, an effective radiosensitizer in lung and pancreatic cancers.

Hastak K, Bhutra S, Parry R, Ford JM. Hastak K, et al. Among authors: ford jm. Oncotarget. 2017 Apr 18;8(16):26344-26355. doi: 10.18632/oncotarget.15464. Oncotarget. 2017. PMID: 28412751 Free PMC article.

2

Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin.

Hastak K, Alli E, Ford JM. Hastak K, et al. Among authors: ford jm. Cancer Res. 2010 Oct 15;70(20):7970-80. doi: 10.1158/0008-5472.CAN-09-4521. Epub 2010 Aug 26. Cancer Res. 2010. PMID: 20798217 Free PMC article.

3

Identification of a Functional In Vivo p53 Response Element in the Coding Sequence of the Xeroderma Pigmentosum Group C Gene.

Hastak K, Adimoolam S, Trinklein ND, Myers RM, Ford JM. Hastak K, et al. Among authors: ford jm. Genes Cancer. 2012 Feb;3(2):131-40. doi: 10.1177/1947601912456288. Genes Cancer. 2012. PMID: 23050045 Free PMC article.

4

Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.

Alli E, Sharma VB, Sunderesakumar P, Ford JM. Alli E, et al. Among authors: ford jm. Cancer Res. 2009 Apr 15;69(8):3589-96. doi: 10.1158/0008-5472.CAN-08-4016. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351835 Free PMC article.

5

Poly (ADP-ribose) polymerase inhibitor LT-626: Sensitivity correlates with MRE11 mutations and synergizes with platinums and irinotecan in colorectal cancer cells.

McPherson LA, Shen Y, Ford JM. McPherson LA, et al. Among authors: ford jm. Cancer Lett. 2014 Feb 28;343(2):217-23. doi: 10.1016/j.canlet.2013.10.034. Epub 2013 Nov 9. Cancer Lett. 2014. PMID: 24215868

6

PARP inhibitors in breast cancer.

Telli ML, Ford JM. Telli ML, et al. Among authors: ford jm. Clin Adv Hematol Oncol. 2010 Sep;8(9):629-35. Clin Adv Hematol Oncol. 2010. PMID: 21157412 Review.

7

Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma.

Chang DT, Chapman CH, Norton JA, Visser B, Fisher GA, Kunz P, Ford JM, Koong AC, Pai RK. Chang DT, et al. Among authors: ford jm. Cancer. 2010 Nov 15;116(22):5179-87. doi: 10.1002/cncr.25481. Cancer. 2010. PMID: 20665497 Free article.

8

Novel treatment approaches for triple-negative breast cancer.

Telli ML, Ford JM. Telli ML, et al. Among authors: ford jm. Clin Breast Cancer. 2010;10 Suppl 1:E16-22. doi: 10.3816/CBC.2010.s.003. Clin Breast Cancer. 2010. PMID: 20587403 Review.

9

Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast cancer.

Anders CK, Winer EP, Ford JM, Dent R, Silver DP, Sledge GW, Carey LA. Anders CK, et al. Among authors: ford jm. Clin Cancer Res. 2010 Oct 1;16(19):4702-10. doi: 10.1158/1078-0432.CCR-10-0939. Epub 2010 Sep 21. Clin Cancer Res. 2010. PMID: 20858840 Free PMC article. Review.

10

BRCA1: Beyond double-strand break repair.

Alli E, Ford JM. Alli E, et al. Among authors: ford jm. DNA Repair (Amst). 2015 Aug;32:165-171. doi: 10.1016/j.dnarep.2015.04.028. Epub 2015 May 1. DNA Repair (Amst). 2015. PMID: 25956865 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

628 results

Search Page